Janssen-Cilag Ltd

50 - 100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG
Telephone: +44 (0)1494 567 567
Fax: +44 (0)1494 567 568
WWW: http://www.janssen-cilag.co.uk
Medical Information Direct Line: +44 (0)800 731 8450
Medical Information e-mail: medinfo@janssen-cilag.co.uk
Customer Care direct line: +44 (0)800 731 5550
Summary of Product Characteristics last updated on the eMC: 04/03/2009
SPC Binovum Oral Contraceptive Tablets.

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 04/03/2009 and displayed until Current
Reasons for adding or updating:
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   23-Feb-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Change to section 9 - Changed to 23 February 2009
Change to section 10 - Changed to 23 February 2009
Updated on 07/05/2008 and displayed until 04/03/2009
Reasons for adding or updating:
  • Change to section 6. 3 - Shelf Life
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   24-Apr-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



Change

eMC - Summary of Change Details Per Section

 

Change to section 6.3 – Shelf Life

Changed from 3 to 2 years

Change to section 6.4 – Special Precautions for Storage

Changed from 25C to 30C

Change to section 10 – Date of revision of the text

Changed to ‘April 2008’

Updated on 01/03/2006 and displayed until 07/05/2008
Reasons for adding or updating:
  • Correction of spelling/typing errors
  • Change to section 10 (date of (partial) revision of the text
Updated on 30/09/2004 and displayed until 01/03/2006
Reasons for adding or updating:
  • Change to section 10 (date of (partial) revision of the text
  • Change from the BAN of the active substance to the rINN
Updated on 19/08/2004 and displayed until 30/09/2004
Reasons for adding or updating:
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 10 (date of (partial) revision of the text
Updated on 16/01/2002 and displayed until 19/08/2004
Reasons for adding or updating:
  • Change to section 4.3 - Contra-indications
  • Change to section 4.4 - Special Warnings and Precautions for Use
Updated on 09/01/2002 and displayed until 16/01/2002
Reasons for adding or updating:
  • Change to section 4.3 - Contra-indications
  • Change to section 4.4 - Special Warnings and Precautions for Use
Updated on 29/08/2001 and displayed until 09/01/2002
Reasons for adding or updating:
  • Transferred from eMC version 1
Updated on 24/08/2001 and displayed until 29/08/2001
Reasons for adding or updating:
  • Transferred from eMC version 1
Updated on 13/02/2001 and displayed until 24/08/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 16/10/2000 and displayed until 13/02/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 03/08/2000 and displayed until 16/10/2000
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 03/08/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   norethisterone
   ethinylestradiol


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk